Singapore has granted its first regulatory approval for an agentic AI-powered clinical documentation tool in healthcare settings.
The Health Sciences Authority recently cleared Anzu by AIGP Health, an AI health tech company founded by a squad of Singaporean clinicians.
The company describes its flagship product as an AI-powered clinical assistant – powered by natural language processing – that does near real-time note taking, summarises patient data, and provides consultation prompts. It also leverages agentic AI to automatically handle patient history-taking, triage, and follow-up, with built-in multilingual support and evidence-based reasoning.
WHY IT MATTERS
The regulatory approval permits the deployment of AIGP's agentic AI scribe in Singaporean clinics and hospitals. Anzu pilots have already been conducted in Singapore and Australia.
AIGP is also working with its implementation partner, Borderless Healthcare Group, to expand into Indonesia and Malaysia. The company is specifically targeting telehealth providers.
Moreover, the company said that the regulatory nod opens up more opportunities to integrate its AI tool with various EMR systems and diagnostic workflows. AIGP's Anzu is platform-agnostic and accessible via low-barrier interfaces like WhatsApp.
Meanwhile, AIGP also shared that it has been certified compliant with System and Organization Controls 2 (SOC 2) security standards for managing customer data. This allows the company to meet various security requirements, such as the European Union's General Data Protection Regulation.
THE LARGER TREND
Following its latest regulatory and security credentials, AIGP is preparing for a seed funding round in the first quarter of 2026.
Additionally, AIGP is also developing an integrated EMR system with voice commands, clinical ordering, and data integration, while exploring future enhancements such as image-based circulatory assessment and multimodal diagnostics.
Another AI scribe in Singapore, Note Buddy, was piloted at SingHealth almost a year ago. Developed by the cluster's Digital Strategy division, the ambient scribe also records conversations with patients, transcribes them with speech-to-text software, and generates structured medical summaries using generative AI.
Singapore continues to enhance its regulatory frameworks for digital health, such as by introducing exemptions and new risk classifications for AI-powered assistive tools.
ON THE RECORD
"[The r]egulatory approval isn’t just a milestone for us; it’s an affirmation of our belief that technology can support, not substitute, the human touch in healthcare," said Dr Anindita Santosa, CEO and one of the founders of AIGP Health.
"This milestone gives us the regulatory trust and momentum to move forward on several fronts – including the development of more modular, specialty-specific features, such as rheumatology and chronic care," she added.
